Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01228448 · ClinicalTrials.gov registry record · NA

In-Room PET in Proton Radiation Therapy

A NA study of Brain Tumor and Head and Neck Tumor, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT01228448 is a NA study of Brain Tumor and Head and Neck Tumor that has completed, run by Massachusetts General Hospital. The registered enrollment target is 59 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01228448, a NA study of Brain Tumor and Head and Neck Tumor, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

The investigational part of this study is using a mobile PET/CT scanner to take images of the participants tumor immediately after they are treated with proton radiation. This allows the participant to be treated and imaged on the same bed. The information obtained may improve the accuracy of treatment and may help to minimize the dose delivered unnecessarily to healthy tissue.

Interventions

  • PROCEDURE PET scan

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2010-10
Est. Completion 2020-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01228448

The ClinicalTrials.gov registry entry for NCT01228448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (79% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which PET scan is the first listed.

NCT01228448 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01228448 about?

NCT01228448 is a clinical study titled "In-Room PET in Proton Radiation Therapy". The investigational part of this study is using a mobile PET/CT scanner to take images of the participants tumor immediately after they are treated with proton radiation. This allows the participant to be treated and imaged on the same bed. The information obtained may improve the accuracy of treatm...

What is the current status of trial NCT01228448?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2010-10. Estimated completion is 2020-01.

What conditions does trial NCT01228448 study?

This clinical trial studies the following conditions: Brain Tumor, Head and Neck Tumor, Skull Base Tumor.

What interventions are being tested in trial NCT01228448?

The interventions under investigation include: PET scan (PROCEDURE).

Who is sponsoring clinical trial NCT01228448?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01228448 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.